Targeting heparanase for cancer therapy at the tumor-matrix interface

被引:24
作者
Sanderson, Ralph D. [1 ,2 ]
Iozzo, Renato V. [3 ,4 ]
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[3] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
关键词
D O I
10.1016/j.matbio.2012.05.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:283 / 284
页数:2
相关论文
共 10 条
[1]   The heparanase system and tumor metastasis: is heparanase the seed and soil? [J].
Arvatz, Gil ;
Shafat, Itay ;
Levy-Adam, Flonia ;
Ilan, Neta ;
Vlodavsky, Israel .
CANCER AND METASTASIS REVIEWS, 2011, 30 (02) :253-268
[2]   Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis [J].
Barash, Uri ;
Cohen-Kaplan, Victoria ;
Dowek, Ilana ;
Sanderson, Ralph D. ;
Ilan, Neta ;
Vlodavsky, Israel .
FEBS JOURNAL, 2010, 277 (19) :3890-3903
[3]   Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer [J].
Casu, Benito ;
Naggi, Annamaria ;
Torri, Giangiacomo .
MATRIX BIOLOGY, 2010, 29 (06) :442-452
[4]   Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling [J].
Fux, Liat ;
Feibish, Nir ;
Cohen-Kaplan, Victoria ;
Gingis-Velitski, Svetlana ;
Feld, Sari ;
Geffen, Chen ;
Vlodavsky, Israel ;
Ilan, Neta .
CANCER RESEARCH, 2009, 69 (05) :1758-1767
[5]   Proteoglycans in cancer biology, tumour microenvironment and angiogenesis [J].
Iozzo, Renato V. ;
Sanderson, Ralph D. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (05) :1013-1031
[6]   Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial [J].
Palumbo, Antonio ;
Larocca, Alessandra ;
Genuardi, Mariella ;
Kotwica, Katarzyna ;
Gay, Francesca ;
Rossi, Davide ;
Benevolo, Giulia ;
Magarotto, Valeria ;
Cavallo, Federica ;
Bringhen, Sara ;
Rus, Cecilia ;
Masini, Luciano ;
Iacobelli, Massimo ;
Gaidano, Gianluca ;
Mitsiades, Constantine ;
Anderson, Kenneth ;
Boccadoro, Mario ;
Richardson, Paul .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07) :1144-1149
[7]  
Parish CR, 1999, CANCER RES, V59, P3433
[8]   SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis [J].
Ritchie, Joseph P. ;
Ramani, Vishnu C. ;
Ren, Yongsheng ;
Naggi, Annamaria ;
Torri, Giangiacomo ;
Casu, Benito ;
Penco, Sergio ;
Pisano, Claudio ;
Carminati, Paolo ;
Tortoreto, Monica ;
Zunino, Franco ;
Vlodavsky, Israel ;
Sanderson, Ralph D. ;
Yang, Yang .
CLINICAL CANCER RESEARCH, 2011, 17 (06) :1382-1393
[9]   Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia [J].
Rosenthal, MA ;
Rischin, D ;
McArthur, G ;
Ribbons, K ;
Chong, B ;
Fareed, J ;
Toner, G ;
Green, MD ;
Basser, RL .
ANNALS OF ONCOLOGY, 2002, 13 (05) :770-776
[10]   Mammalian heparanase: what is the message? [J].
Vreys, Veronique ;
David, Guido .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (03) :427-452